Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 54, Issue 4, 2016, Pages 1395-1408

  Racine, Annie M ^b,c   Clark, Lindsay R ^a,b   Berman, Sara E ^b   Koscik, Rebecca L ^b   Mueller, Kimberly D ^b   Norton, Derek ^b   Nicholas, Christopher R ^a   Blennow, Kaj ^e,f   Zetterberg, Henrik ^e,f,g   Jedynak, Bruno ^h   Bilgel, Murat ^i,j   Carlsson, Cynthia M ^a,b   Christian, Bradley T ^b,d   Asthana, Sanjay ^a,b   Johnson, Sterling C ^a,b,c,d  

^a WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h PORTLAND STATE UNIVERSITY   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j NATIONAL INSTITUTE ON AGING   (United States)

more..

Author keywords

Amyloid, biomarkers; cerebrospinal fluid; cognitive impairment; CogState; computerized cognitive testing; neural injury; preclinical Alzheimer's disease

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; NEUROFILAMENT PROTEIN; TAU PROTEIN; AMYLOID BETA PROTEIN;

ABBREVIATED COGSTATE BATTERY; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; COGNITION; COGNITION ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CELL LESION; NEUROPSYCHOLOGICAL TEST; ONE CARD LEARNING TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; COHORT ANALYSIS; LONGITUDINAL STUDY; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; REGISTER; RISK FACTOR; STANDARDS;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOMARKERS; COGNITION; COGNITIVE DYSFUNCTION; COHORT STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; REGISTRIES; RISK FACTORS; TAU PROTEINS;

EID: 84992127818     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-160528     Document Type: Article

References (58)

1. Hammers D, Spurgeon E, Ryan K, Persad C, Heidebrink J, Barbas N, Albin R, Frey K, Darby D, Giordani B (2011) Reliability of repeated cognitive assessment of dementia using a brief computerized battery. Am J Alzheimers Dis Other Demen 26, 326-333
2. Lim YY, Jaeger J, Harrington K, Ashwood T, Ellis KA, Stoffler A, Szoeke C, Lachovitzki R, Martins RN, Villemagne VL, Bush A, Masters CL, Rowe CC, Ames D, Darby D, Maruff P (2013) Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimers disease: Results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS). Arch Clin Neuropsychol 28, 320-330
3. Lim YY, Maruff P, Pietrzak RH, Ellis KA, Darby D, Ames D, Harrington K, Martins RN, Masters CL, Szoeke C, Savage G, Villemagne VL, Rowe CC, AIBL Research Group (2014) Abeta and cognitive change: Examining the preclinical and prodromal stages of Alzheimers disease. Alzheimers Dement 10, 743-751 e741
4. Maruff P, Lim YY, Darby D, Ellis KA, Pietrzak RH, Snyder PJ, Bush AI, Szoeke C, Schembri A, Ames D, Masters CL, AIBL Research, Group (2013) Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimers disease. BMC Psychol 1, 30
5. Lim YY, Ellis KA, Harrington K, Ames D, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Darby D, Maruff P, Research AIBL, Group (2012) Use of the CogState Brief Battery in the assessment of Alzheimers disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. J Clin Exp Neuropsychol 34, 345-358
6. Darby DG, Brodtmann A, Pietrzak RH, Fredrickson J, Woodward M, Villemagne VL, Fredrickson A, Maruff P, Rowe C (2011) Episodic memory decline predicts corti cal amyloid status in community-dwelling older adults. J Alzheimers Dis 27, 627-637
7. Lim YY, Pietrzak RH, Bourgeat P, Ames D, Ellis KA, Rembach A, Harrington K, Salvado O, Martins RN, Snyder PJ, Masters CL, Rowe CC, Villemagne VL, Maruff P (2015) Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Abeta accumulation in cognitively normal older adults and adults with MCI. Arch Clin Neuropsychol 30, 49-58
8. Lim YY, Ellis KA, Harrington K, Pietrzak RH, Gale J, Ames D, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Maruff P (2013) Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-beta: Prodromal Alzheimers disease? J Alzheimers Dis 33, 1167-1176
9. Lim YY, Villemagne VL, Pietrzak RH, Ames D, Ellis KA, Harrington K, Snyder PJ, Martins RN, Masters CL, Rowe CC, Maruff P, Australian Imaging, Biomarkers, and Lifestyle (AIBL) Research Group (2015) APOE epsilon4 moderates amyloid-related memory decline in preclinical Alzheimers disease. Neurobiol Aging 36, 1239-1244
10. Thai C, Lim YY, Villemagne VL, Laws SM, Ames D, Ellis KA, Rainey-Smith SR, Martins RN, Masters CL, Rowe CC, Maruff P, Australian Imaging, Biomarkers and Lifestyle (AIBL) Research Group (2015) Amyloid-related memory decline in preclinical Alzheimers disease is dependent on APOEepsilon4 and is detectable over 18-months. PLoS One 10, e0139082
11. Mielke MM, Machulda MM, Hagen CE, Edwards KK, Roberts RO, Pankratz VS, Knopman DS, Jack CR Jr, Petersen RC (2015) Performance of the CogState computerized battery in the Mayo Clinic Study on Aging. Alzheimers Dement 11, 1367-1376
12. Mielke MM, Weigand SD, Wiste HJ, Vemuri P, Machulda MM,Knopman DS, LoweV, RobertsRO, Kantarci K, Rocca WA, Jack CR Jr, Petersen RC (2014) Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging. Alzheimers Dement 10, 779-789
13. Mattsson N, Insel PS, Donohue M, Landau S, Jagust WJ, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner MW, Alzheimers Disease Neuroimaging Initiative (2015) Independent information from cerebrospinal fluid amyloid-beta and florbetapir imaging in Alzheimers disease. Brain 138, 772-783
14. Palmqvist S, Mattsson N, Hansson O, Alzheimers Disease Neuroimaging Initiative (2016) Cerebrospinal fluid analysis detects cerebral amyloid-beta accumulation earlier than positron emission tomography. Brain 139, 1226-1236
15. Sager MA, Hermann B, La Rue A (2005) Middle-aged children of persons with Alzheimers disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimers Prevention. J Geriatr Psychiatry Neurol 18, 245-249
16. Jonaitis E, La Rue A, Mueller KD, Koscik RL, Hermann B, Sager MA (2013) Cognitive activities and cognitive performance in middle-aged adults at risk for Alzheimers disease. Psychol Aging 28, 1004-1014
17. Koscik RL, La Rue A, Jonaitis EM, Okonkwo OC, Johnson SC, Bendlin BB, HermannBP, SagerMA(2014) Emergence of mild cognitive impairment in late middle-aged adults in the wisconsin registry for Alzheimers prevention. Dement Geriatr Cogn Disord 38, 16-30
18. Clark LR, Koscik RL, Nicholas CR, Okonkwo OC, Engelman CD, Bratzke LC, Hogan KJ, Mueller KD, Bendlin BB, Carlsson CM, Asthana S, Sager MA, Hermann BP, Johnson SC (2016) Mild cognitive impairment in late middle age in the Wisconsin Registry for Alzheimers Prevention Study: Prevalence and characteristics using robust and standard neuropsychological normative data. Arch Clin Neuropsychol, doi: 10.1093/arclin/acw024
19. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, PhelpsCH(2011) The diagnosis of mild cognitive impairment due to Alzheimers disease: Recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement 7, 270-279
20. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimers disease: Recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement 7, 263-269
21. Cogstate (2011) Cogstate: Melbourne, Australia
22. Schmidt M (1996) Rey Auditory Verbal Learning Test: A Handbook., Western Psychological Services, Los Angeles
23. Wechsler D (1987) Wechsler Memory Scale-Revised. The Psychological Corporation, Harcourt Brace Jovanovich, Inc. for Psychological Corp., New York
24. Benedict RHB, Schretlen D, Groninger L, Dobraski M, Shpritz B (1996) Revision of the Brief Visuospatial Memory Test: Studies of normal performance, reliability, and validity. Psychol Assess 8, 145-153
25. Kaplan E, Goodglass H,Weintraub S (2001) Boston Naming Test-Second Edition. PRO-ED, Inc., Austin, TX
26. Rosen WG (1980) Verbal fluency in aging and dementia. J Clin Neuropsychol 2, 135-146
27. Benton AL, Hamsher KS, Sivan AB (1994) Multilingual aphasia examination, Psychological Assessment Resources, Lutz, FL
28. Trenerry MR, Crosson B, DeBoe J, LeberWR(1989) Stroop Neuropsychological Screening Test. Psychological Assessment Resources, Inc., Odessa, FL
29. Reitan R (1958) Validity of the Trail Making test as an indicator of organic brain damage. Percept Mot Skills 8, 271-276
30. Wechsler D (1987) Wechsler Adult Intelligence Scale-Revised, The Psychological Corporation, San Antonio
31. Wechsler D (1997) Wechsler Adult Intelligence Scale-3rd Edition. Harcourt Assessment, San Antonio, TX
32. Folstein MF, Folstein SE, McHugh PR (1975) Minimental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198
33. Bilgel M, Jedynak B, Wong DF, Resnick SM, Prince JL (2015) Temporal trajectory and progression score estimation from voxelwise longitudinal imaging measures: Application to amyloid imaging. Inf Process Med Imaging 24, 424-436
34. Jedynak BM, Lang A, Liu B, Katz E, Zhang Y,Wyman BT, Raunig D, Jedynak CP, Caffo B, Prince JL, Alzheimers Disease Neuroimaging Initiative (2012) A computational neurodegenerative disease progression score: Method and results with the Alzheimers disease Neuroimaging Initiative cohort. Neuroimage 63, 1478-1486
35. Bilgel M, Prince JL, Wong DF, Resnick SM, Jedynak BM (2016)Amultivariate nonlinear mixed effects model for longitudinal image analysis: Application to amyloid imaging. Neuroimage
36. Johnson SC, Christian BT, Okonkwo OC, Oh JM, Harding S, Xu G, Hillmer AT, Wooten DW, Murali D, Barnhart TE, Hall LT, Racine AM, Klunk WE, Mathis CA, Bendlin BB, Gallagher CL, Carlsson CM, Rowley HA, Hermann BP, Dowling NM, Asthana S, Sager MA (2014) Amyloid burden and neural function in people at risk for Alzheimers Disease. Neurobiol Aging 35, 576-584
37. Racine AM, Adluru N, Alexander AL, Christian BT, Okonkwo OC, Oh J, Cleary CA, Birdsill A, Hillmer AT, Murali D, Barnhart TE, Gallagher CL, Carlsson CM, Rowley HA, Dowling NM, Asthana S, Sager MA, Bendlin BB, Johnson SC (2014) Associations between white matter microstructure and amyloid burden in preclinical Alzheimers disease: A multimodal imaging investigation. Neuroimage Clin 4, 604-614
38. Sprecher KE, Bendlin BB, Racine AM, Okonkwo OC, Christian BT, Koscik RL, Sager MA, Asthana S, Johnson SC, Benca RM (2015) Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults. Neurobiol Aging 36, 2568-2576
39. Racine AM, Koscik RL, Nicholas CR, Clark LR, Okonkwo OC, Oh JM, Hillmer AT,Murali D, Barnhart TE, Betthauser TJ, Gallagher CL, Rowley HA, Dowling NM, Asthana S, Bendlin BB, BlennowK, ZetterbergH, Carlsson CM, Christian BT, Johnson SC (2016) Cerebrospinal fluid ratios with Abeta42 predict preclinical brain beta-amyloid accumulation. Alzheimers Dement (Amst) 2, 27-38
40. Almeida RP, Schultz SA, Austin BP, Boots EA, Dowling NM, Gleason CE, Bendlin BB, Sager MA, Hermann BP, Zetterberg H, Carlsson CM, Johnson SC, Asthana S, Okonkwo OC (2015) Effect of cognitive reserve on age-related changes in cerebrospinal fluid biomarkers of Alzheimer disease. JAMA Neurol 72, 699-706
41. Starks EJ, Patrick OGrady J, Hoscheidt SM, Racine AM, Carlsson CM, Zetterberg H, Blennow K, Okonkwo OC, Puglielli L, Asthana S,DowlingNM,Gleason CE, Anderson RM, Davenport-Sis NJ, DeRungs LM, Sager MA, Johnson SC, Bendlin BB (2015) Insulin resistance is associated with higher cerebrospinal fluid tau levels in asymptomatic APOEepsilon4 carriers. J Alzheimers Dis 46, 525-533
42. Cohen J (1992) A power primer. Psychol Bull 112, 155-159
43. Backman L, Jones S, Berger AK, Laukka EJ, Small BJ (2005) Cognitive impairment in preclinical Alzheimers disease: A meta-analysis. Neuropsychology 19, 520-531
44. Weintraub S, Wicklund AH, Salmon DP (2012) The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med 2, a006171
45. Salmon DP, BondiMW(2009) Neuropsychological assessment of dementia. Annu Rev Psychol 60, 257-282
46. Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences-2nd edition. Erlbaum, Hillsdale, New Jersey
47. Villain N, Chetelat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL, AIBL Research Group (2012) Regional dynamics of amyloid-beta deposition in healthy elderly, mild cognitive impairment and Alzheimers disease: A voxelwise PiB-PET longitudinal study. Brain 135, 2126-2139
48. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, MullerM(2011) pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12, 77
49. Youden WJ (1950) Index for rating diagnostic tests. Cancer 3, 32-35
50. Snyder PJ, Jackson CE, Petersen RC, Khachaturian AS, Kaye J, Albert MS,Weintraub S (2011) Assessment of cognition in mild cognitive impairment: A comparative study. Alzheimers Dement 7, 338-355
51. Wild K, Howieson D,Webbe F, Seelye A, Kaye J (2008) Status of computerized cognitive testing in aging: A systematic review. Alzheimers Dement 4, 428-437
52. Fredrickson J, Maruff P,Woodward M, Moore L, Fredrickson A, Sach J, Darby D (2010) Evaluation of the usability of a brief computerized cognitive screening test in older people for epidemiological studies. Neuroepidemiology 34, 65-75
53. Zygouris S, TsolakiM(2015) Computerized cognitive testing for older adults: A review. Am J Alzheimers Dis Other Demen 30, 13-28
54. Hammers D, Spurgeon E, Ryan K, Persad C, Barbas N, Heidebrink J, Darby D, Giordani B (2012) Validity of a brief computerized cognitive screening test in dementia. J Geriatr Psychiatry Neurol 25, 89-99
55. Maruff P, Collie A, Darby D, Weaver-Cargin J, Masters C, Currie J (2004) Subtle memory decline over 12 months in mild cognitive impairment. Dement Geriatr Cogn Disord 18, 342-348
56. Mielke MM, Machulda MM, Hagen CE, Christianson TJ, Roberts RO, Knopman DS, Vemuri P, Lowe VJ, Kremers WK, Jack CR Jr, Petersen RC (2016) Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort. Alzheimers Dement 12, 281-291
57. Goldberg TE, Harvey PD, Wesnes KA, Snyder PJ, Schneider LS (2015) Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimers disease randomized controlled trials. Alzheimers Dement (Amst) 1, 103-111
58. Beglinger LJ, Gaydos B, Tangphao-Daniels O, Duff K, Kareken DA, Crawford J, Fastenau PS, Siemers ER (2005) Practice effects and the use of alternate forms in serial neuropsychological testing. Arch Clin Neuropsychol 20, 517-529